Key Points
- Steve Foots bought 5 shares on April 10 at GBX 2,950 (£147.50) but earlier sold 3,622 shares on March 17 for ~£94,389, suggesting mixed insider activity of small purchases alongside a large disposal.
- Analysts hold a consensus "Moderate Buy" with a price target of GBX 3,140; Morgan Stanley upgraded to "overweight" and raised its target to GBX 3,350 while Deutsche Bank cut its target to GBX 3,000.
- Croda carries a market capitalization of £4.09 billion, a high P/E of 66.08 and a low net margin of 3.65%, trading in a 52-week range of GBX 2,426.77–3,312.
Croda International Plc (LON:CRDA - Get Free Report) insider Steve Foots bought 5 shares of Croda International stock in a transaction that occurred on Friday, April 10th. The stock was purchased at an average price of GBX 2,950 per share, with a total value of £147.50.
Steve Foots also recently made the following trade(s):
- On Tuesday, March 17th, Steve Foots sold 3,622 shares of Croda International stock. The shares were sold at an average price of GBX 2,606, for a total value of £94,389.32.
- On Tuesday, March 10th, Steve Foots acquired 6 shares of Croda International stock. The shares were bought at an average price of GBX 2,798 per share, with a total value of £167.88.
- On Tuesday, February 10th, Steve Foots acquired 5 shares of Croda International stock. The shares were bought at an average price of GBX 3,100 per share, with a total value of £155.
Croda International Stock Performance
LON CRDA opened at GBX 2,934 on Tuesday. The stock has a 50-day simple moving average of GBX 2,881.77 and a two-hundred day simple moving average of GBX 2,807.96. The firm has a market capitalization of £4.09 billion, a P/E ratio of 66.08, a PEG ratio of 1.40 and a beta of 0.94. Croda International Plc has a fifty-two week low of GBX 2,426.77 and a fifty-two week high of GBX 3,312. The company has a debt-to-equity ratio of 31.85, a quick ratio of 2.25 and a current ratio of 1.99.
Croda International (LON:CRDA - Get Free Report) last released its quarterly earnings data on Tuesday, February 24th. The company reported GBX 146.20 earnings per share for the quarter. Croda International had a return on equity of 2.82% and a net margin of 3.65%. On average, equities analysts forecast that Croda International Plc will post 181.8307268 earnings per share for the current year.
Analysts Set New Price Targets
A number of equities analysts have weighed in on the company. Morgan Stanley upgraded Croda International to an "overweight" rating and lifted their price objective for the company from GBX 3,280 to GBX 3,350 in a research note on Wednesday, March 25th. Deutsche Bank Aktiengesellschaft reduced their price objective on Croda International from GBX 3,100 to GBX 3,000 and set a "hold" rating for the company in a research note on Tuesday, March 24th. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of GBX 3,140.
View Our Latest Stock Report on CRDA
Croda International Company Profile
(
Get Free Report)
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
